Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping-Ying Chang

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
European Journal of Gastroenterology & Hepatology|January 4, 2014
Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolizationCheng-Hsiang Lo, Wen-Yen Huang, Meei-Shyuan Lee, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 27, 2014
Gefitinib as first-line treatment for patients with epidermal growth factor receptor-mutated advanced lung adenocarcinoma: a single institution experience in TaiwanShiue-Wei Lai, Ching-Liang Ho, Ming-Shen Dai, et al.
Plos One|May 25, 2019
The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based studyPing-Ying Chang, Chi-Hsiang Chung, Wei-Chou Chang, et al.
European Journal of Radiology|August 23, 2020
Time to peak enhancement of malignant hypervascular hepatic tumors versus that of the aorta evaluating by test bolus sequence of magnetic resonance imagingSung-Hua Chiu, Yu-Lueng Shih, Guo-Shu Huang, et al.
American Journal of Cancer Research|July 15, 2024
Heterogenous liver parenchymal enhancement in CT is a favorable prognosis of HCC after hepatic resectionHsuan-Hwai Lin, Yi-Jen Peng, Chao-Feng Chang, et al.
Leukemia & Lymphoma|November 11, 2014
Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab eraChieh-Sheng Lu, Jia-Hong Chen, Tzu-Chuan Huang, et al.
Journal of Clinical Medicine|December 10, 2021
The Effect of Statins in Cancer Risk Reduction in Patients on Dialysis: A Population-Based Case-Control StudyPo-Huang Chen, Hong-Jie Jhou, Chi-Hsiang Chung, et al.
Cells|August 28, 2024
Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine SDF-1/CXCR4 Signaling Promotes Stemness and Aggressiveness of Colorectal CancersChao-Yang Chen, Shih-Hsien Yang, Ping-Ying Chang, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 18, 2015
The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexiaYi-Ying Wu, Tsu-Yi Chao, Hsin-Yi Liu, et al.
Journal of the Chinese Medical Association : JCMA|February 13, 2022
Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shuntPin-Ko Chen, Sung-Hua Chiu, Ming-Ting Tsai, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
European Journal of Gastroenterology & Hepatology|January 4, 2014
Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma patients who failed or were unsuitable for transarterial chemoembolizationCheng-Hsiang Lo, Wen-Yen Huang, Meei-Shyuan Lee, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 27, 2014
Gefitinib as first-line treatment for patients with epidermal growth factor receptor-mutated advanced lung adenocarcinoma: a single institution experience in TaiwanShiue-Wei Lai, Ching-Liang Ho, Ming-Shen Dai, et al.
Plos One|May 25, 2019
The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based studyPing-Ying Chang, Chi-Hsiang Chung, Wei-Chou Chang, et al.
European Journal of Radiology|August 23, 2020
Time to peak enhancement of malignant hypervascular hepatic tumors versus that of the aorta evaluating by test bolus sequence of magnetic resonance imagingSung-Hua Chiu, Yu-Lueng Shih, Guo-Shu Huang, et al.
American Journal of Cancer Research|July 15, 2024
Heterogenous liver parenchymal enhancement in CT is a favorable prognosis of HCC after hepatic resectionHsuan-Hwai Lin, Yi-Jen Peng, Chao-Feng Chang, et al.
Leukemia & Lymphoma|November 11, 2014
Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab eraChieh-Sheng Lu, Jia-Hong Chen, Tzu-Chuan Huang, et al.
Journal of Clinical Medicine|December 10, 2021
The Effect of Statins in Cancer Risk Reduction in Patients on Dialysis: A Population-Based Case-Control StudyPo-Huang Chen, Hong-Jie Jhou, Chi-Hsiang Chung, et al.
Cells|August 28, 2024
Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine SDF-1/CXCR4 Signaling Promotes Stemness and Aggressiveness of Colorectal CancersChao-Yang Chen, Shih-Hsien Yang, Ping-Ying Chang, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 18, 2015
The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexiaYi-Ying Wu, Tsu-Yi Chao, Hsin-Yi Liu, et al.
Journal of the Chinese Medical Association : JCMA|February 13, 2022
Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shuntPin-Ko Chen, Sung-Hua Chiu, Ming-Ting Tsai, et al.
Pageof 6